Buserelin is approved for the treatment of hormone-responsive cancers including prostate cancer and premenopausal breast cancer, sex hormone-dependent uterine diseases including endometrial hyperplasia, endometriosis, and uterine fibroids, and in assisted reproduction for female infertility. Reference standards of Buserelin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
Buserelin
Catalogue No.:PA 29 47000
CAS :
Molecular Formula : C60H86N16O13
Molecular Weight : 1239.42
Buserelin (B1168000)
Catalogue No.:PA EPB1168000
Molecular Formula : NA
Molecular Weight : NA
Buserelin for NMR identification (Y0001814)
Catalogue No.:PA EPY0001814
Buserelin for peak identification (Y0001740)
Catalogue No.:PA EPY0001740
D-His-Buserelin (B1168020)
Catalogue No.:PA EPB1168020
D-His-Buserelin
Catalogue No.:PA 29 0471000
Molecular Weight : 1239.45
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
